Tse D M W, Chan K S, Lam W M, Leu Ks, Lam P T
Department of Medicine and Geriatrics, Caritas Medical Centre, Sham Shui Po, Kowloon, Hong Kong SAR.
Palliat Med. 2007 Jul;21(5):425-33. doi: 10.1177/0269216307079825.
To study the utilization of public health care by advanced cancer patients in their last 6 months of life and their end-of-life process within the last 2 weeks of life.
This was a retrospective study on 494 cancer deaths from four public hospitals in 2005. This sample was selected from all in-patient cancer deaths by the ratio of one in four. Data were collected by review of charts and an electronic data base.
A total of 494 cancer deaths were analysed. The mean age of all cancer patients (n = 494) was 72.6 years. Two-thirds of cancer patients received palliative care and half died in palliative care setting. Patients were categorized into three groups according to palliative care coverage and the place of death. The first group comprised of patients who received palliative care service and died in palliative care units (PCS-PCD group, n = 247); the second group of patients who received palliative care service within the last 6 months of life but died in non-palliative care wards (n = 86); and the third group of patients who never received palliative care and who died in non-palliative care wards (NPCS-NPCD group, n = 161). Differences among groups were tested by one way ANOVA. During the last 6 months of life, patients in the PCS-PCD group had less admission to acute care wards (P = 0.012), shorter duration of stay in acute care wards (P = 0.003), and less admission to an intensive care unit setting (P < 0.001). Within the last 2 weeks of life, the PCS-PCD group had fewer interventions initiated (P < 0.001); had higher number of symptoms documented in patient's record (P < 0.001); and were more likely to receive analgesics (P < 0.001), adjuvant analgesics (P < 0.001) and sedatives (P < 0.001). Patients in PCS-PCD group were more physically dependent in the last 2 weeks of life (P < 0.001), but mentally more alert at 72 hours before death (P < 0.001). Patients in the NPCS-NPCD group had fewer patients with a do not resuscitate order present (P < 0.001), and more patients with cardiopulmonary resuscitation performed (P < 0.001).
Our results suggest that palliative care service has played a role in improving end-of-life cancer care in Hong Kong.
研究晚期癌症患者在生命的最后6个月内对公共卫生保健的利用情况以及他们在生命的最后2周内的临终过程。
这是一项对2005年来自四家公立医院的494例癌症死亡病例的回顾性研究。该样本是从所有住院癌症死亡病例中按四分之一的比例选取的。通过查阅病历和电子数据库收集数据。
共分析了494例癌症死亡病例。所有癌症患者(n = 494)的平均年龄为72.6岁。三分之二的癌症患者接受了姑息治疗,半数在姑息治疗环境中死亡。根据姑息治疗覆盖情况和死亡地点将患者分为三组。第一组包括接受姑息治疗服务并在姑息治疗病房死亡的患者(PCS - PCD组,n = 247);第二组是在生命的最后6个月内接受了姑息治疗服务但在非姑息治疗病房死亡的患者(n = 86);第三组是从未接受过姑息治疗且在非姑息治疗病房死亡的患者(NPCS - NPCD组,n = 161)。通过单因素方差分析检验组间差异。在生命的最后6个月内,PCS - PCD组患者入住急症病房的次数较少(P = 0.012),在急症病房的住院时间较短(P = 0.003),入住重症监护病房的次数较少(P < 0.001)。在生命的最后2周内,PCS - PCD组启动的干预措施较少(P < 0.001);患者病历中记录的症状数量较多(P < 0.001);更有可能接受镇痛药(P < 0.001)、辅助镇痛药(P < 0.001)和镇静剂(P < 0.001)。PCS - PCD组患者在生命的最后2周身体依赖性更强(P < 0.001),但在死亡前72小时精神更清醒(P < 0.001)。NPCS - NPCD组中下达不进行心肺复苏医嘱的患者较少(P < 0.001),接受心肺复苏的患者较多(P < 0.001)。
我们的结果表明,姑息治疗服务在改善香港的癌症临终护理方面发挥了作用。